All-stock transactions will give Quanome approximately 5% stake in QAI Labs, the developer of NOVA-3, an AI-enabled platform designed for multi-specific antibody discovery Quanome intends to support QAI Labs' development through its investment, strategic engagement and relevant relationships across its Scientific Advisory Network and broader ecosystem. The Company will seek opportunities to strengthen scientific review, technical capability, validation pathways and complementary life- sciences partnerships ...